Over the past few decades, scientists and researchers have significantly progressed in diagnostic and therapeutic techniques for movement disorders. The progress in genetics and the growth of advanced therapies, the latter based mostly on brain modulation techniques, have led to numerous reports and cases in the field. However, several such submissions are actually reshaping clinical journals, gaining space within their pages, and competing with the reports on the classic clinical art of medicine. We as editors of MDCP, since its inception, have watched these developments and have been proactive to allow for this in the journal.
In this regard we introduced a subsection Genotype & Phenotype Letters (“GP Letters”) 2 years ago. This has been very successful and popular amongst authors and readers and has provided a platform for a number of case reports with new variants in genotype and/or phenotypes.
Understanding the brain's workings and circuitry and developing new techniques to modulate its activity has been the basis of many current advanced therapies for movement disorders. Whether these be invasive or noninvasive or through ablative or deep brain stimulation (DBS) techniques, this is a rapidly evolving field with new discoveries and innovations emerging every day. The complex process of DBS programming with a high involvement of neurologists, which requires expertise and exquisite clinical skills, is generating an increasing number of reports worth publishing and barely finding a proper place within the current portfolio of mainstream journals.
Therefore, as we did a few years ago with the GP letters, we want now to introduce a new subsection of MDCP: Neuromodulation Letters (“NM Letters”). This section will serve as a platform for researchers, clinicians, and scientists to share their latest findings and innovations in this area promoting the dissemination of knowledge and accelerating the pace of discovery. These papers will become an essential resource for those interested in Brain Modulation and its applications in movement disorders.
We encourage submissions from researchers and clinicians in the field of DBS, Ablative surgery, Transcranial magnetic stimulation and any other forms of neuromodulation. We look forward to this new feature's wealth of knowledge and insights.